ARTICLE | Clinical News
Bionomics preclinical data
November 15, 2004 8:00 AM UTC
In a xenograft mouse model of breast cancer, BN069, a gene silencing molecule, reduced tumor size by 75% compared to untreated tumors. Data were presented at the Vascular Targeting Agents meeting in C...